Lenka Bartošíková

2.1k total citations · 2 hit papers
26 papers, 1.6k citations indexed

About

Lenka Bartošíková is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Lenka Bartošíková has authored 26 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Complementary and alternative medicine and 6 papers in Pharmacology. Recurrent topics in Lenka Bartošíková's work include Medicinal Plants and Neuroprotection (3 papers), Metabolism and Genetic Disorders (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Lenka Bartošíková is often cited by papers focused on Medicinal Plants and Neuroprotection (3 papers), Metabolism and Genetic Disorders (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Lenka Bartošíková collaborates with scholars based in Czechia and Slovakia. Lenka Bartošíková's co-authors include Josef Nečas, Jiří Nečas, P. Brauner, J Kolár, Václav Suchý, El Moataz Bellah El Naggar, Milan Žemlička, Martin Modrianský, Emil Švajdlenka and Miloslava Rabišková and has published in prestigious journals such as PLoS ONE, Fitoterapia and Medicina.

In The Last Decade

Lenka Bartošíková

26 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hyaluronic acid (hyaluronan): a review

2008 762 citations Jiří Nečas, Lenka Bartošíková et al. Veterinární Medicína profile →
Carrageenan: a review

2013 654 citations Lenka Bartošíková et al. Veterinární Medicína profile →

Peers

Lenka Bartošíková

MB

BIOMA

FS

AS

CB

Zwe‐Ling Kong Taiwan

Yanfei Peng China

Chien-Ho Chen Taiwan

Liqun Yang China

J. Helen Fitton Australia

Yinping Li China

Peixue Ling China

Xia Zhao China

Kyong‐Hwa Kang South Korea

Giuseppe Tripodo Italy

Zwe‐Ling Kong Taiwan

Lenka Bartošíková

498 ×1.6

MB

270 ×0.9

BIOMA

107 ×0.4

FS

270 ×1.0

AS

62 ×0.2

CB

Citations per year, relative to Lenka Bartošíková Lenka Bartošíková (= 1×) peers Zwe‐Ling Kong

Countries citing papers authored by Lenka Bartošíková

Since Specialization

Citations

This map shows the geographic impact of Lenka Bartošíková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lenka Bartošíková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lenka Bartošíková more than expected).

Fields of papers citing papers by Lenka Bartošíková

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lenka Bartošíková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lenka Bartošíková. The network helps show where Lenka Bartošíková may publish in the future.

Co-authorship network of co-authors of Lenka Bartošíková

This figure shows the co-authorship network connecting the top 25 collaborators of Lenka Bartošíková. A scholar is included among the top collaborators of Lenka Bartošíková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lenka Bartošíková. Lenka Bartošíková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Bartošíková, Lenka, et al.. (2018). Cardioprotective effect of 2,3-dehydrosilybin preconditioning in isolated rat heart. Fitoterapia. 132. 12–21. 13 indexed citations

2.

Bartošíková, Lenka, et al.. (2015). Silymarin Constituent 2,3-Dehydrosilybin Triggers Reserpine-Sensitive Positive Inotropic Effect in Perfused Rat Heart. PLoS ONE. 10(9). e0139208–e0139208. 9 indexed citations

3.

Bartošíková, Lenka, et al.. (2010). Effect of pomiferin administration on kidney ischaemia-reperfusion injury in rats. Interdisciplinary Toxicology. 3(2). 76–81. 6 indexed citations

4.

Bartošíková, Lenka, et al.. (2008). CHANGES IN BIOMECHANICAL PARAMETERS DURING HEART PERFUSION AND AFTER MIDAZOLAM PRE-MEDICATION - EXPERIMENTAL PILOT STUDY. Biomedical Papers. 152(1). 79–82. 5 indexed citations

5.

Nečas, Jiří, Lenka Bartošíková, P. Brauner, & J Kolár. (2008). Hyaluronic acid (hyaluronan): a review. Veterinární Medicína. 53(8). 397–411. 762 indexed citations breakdown →

6.

Nečas, Jiří, et al.. (2007). Protective Effects of Flavonoid Pomiferin on Heart Ischemia-Reperfusion. Acta Veterinaria Brno. 76(3). 363–370. 2 indexed citations

7.

Bartošíková, Lenka, et al.. (2007). [Examination of the antioxidative and antidiabetic effect of pomiferin in alloxan-induced diabetes mellitus in an experiment (a pilot study)].. PubMed. 56(3). 135–40. 4 indexed citations

8.

Bartošíková, Lenka, et al.. (2006). [Morin in the therapy of the ischemia-reperfusion damage model of the rat kidney].. PubMed. 55(2). 78–83. 2 indexed citations

9.

Bébarová, Markéta, et al.. (2006). Ultrashort Bradycardic Effect of Newly Synthesized Compounds. Acta Veterinaria Brno. 75(2). 183–196. 2 indexed citations

10.

Nečas, Jiří, et al.. (2006). EFFECTS OF PRENYLATED ISOFLAVONES OSAJIN AND POMIFERIN IN PREMEDICATION ON HEART ISCHEMIA-REPERFUSION. Biomedical Papers. 150(1). 93–100. 28 indexed citations

11.

Nečas, Jiří, et al.. (2006). [Protective effects of the flavonoids osajin and pomiferin on heart ischemia-reperfusion].. PubMed. 55(4). 168–74. 9 indexed citations

12.

Bartošíková, Lenka, et al.. (2006). [Prophylactic administration of homoisoflavonoid in ischemic-reperfusion damage of the renal tissue in the laboratory rat].. PubMed. 55(1). 24–8. 1 indexed citations

13.

Bartošíková, Lenka, et al.. (2005). Effects of Pomiferin Premedication on the Antioxidant Status of Rats with Ischemia-Reperfused Kidney. Acta Veterinaria Brno. 74(4). 557–564. 6 indexed citations

14.

Naggar, El Moataz Bellah El, et al.. (2005). Antidiabetic Effect of Cleome droserifolia Aerial Parts: Lipid Peroxidation-Induced Oxidative Stress in Diabetic Rats. Acta Veterinaria Brno. 74(3). 347–352. 37 indexed citations

15.

Nečas, Jiří, et al.. (2004). Influence of New Ultrashort-Acting Beta-Adrenergic Blockers on Systolic Blood Pressure in Rats. Acta Veterinaria Brno. 73(2). 181–185. 4 indexed citations

16.

Bartošíková, Lenka, Jiří Nečas, Václav Suchý, et al.. (2003). Antioxidative Effects of Morine in Ischemia-Reperfusion of Kidneys in the Laboratory Rat. Acta Veterinaria Brno. 72(1). 87–94. 9 indexed citations

17.

Bartošíková, Lenka, Jiří Nečas, Václav Suchý, et al.. (2003). Monitoring of Antioxidative Effect of Morine in Alloxan-induced Diabetes mellitus in the Laboratory Rat. Acta Veterinaria Brno. 72(2). 191–200. 16 indexed citations

18.

Bartošíková, Lenka, et al.. (2002). Effects of carvedilol and BL-443 on kidney of rats with cyclosporine nephropathy.. PubMed. 21(2). 189–95. 6 indexed citations

19.

Kollár, Péter, et al.. (2000). [Experimental study of resveratrol and flavonoids in red wine with regard to their possible hypolipemic effects].. PubMed. 46(12). 856–60. 6 indexed citations

20.

Nečas, Jiří, et al.. (1997). [The effects of Carvedilol, a beta-blocker, in experimental ischemia-reperfusion kidney injury].. PubMed. 43(11). 707–11. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact